Patent · US Active

Imidazole derivative used as antiviral agent and use therof in preparation of medicament

US9850251B2 · kind B2 · utility

1Cited by

4References

18Claims

0Family size

Assignee

SHANDONG DANHONG PHARMACEUTICAL CO., LTD. · CN

Inventors

Haiying He · Shanghai, CN
Weihua Shi · 红钢城街道, CN
Zhigan Jiang · Shanghai, CN
Lixia Han · Shanghai, CN
Jikui SUN · Shanghai, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Nov 11, 2014
Grant date	Dec 26, 2017
Priority date	—
Expiry date	Nov 11, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are an antiviral compound and a use thereof in the preparation of a medicament for the treatment of virus infections. Specifically, the present invention relates an imidazole derivative for treating respiratory syncytial virus infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.